Article Text

Download PDFPDF
CP-131 Review of neutropenic fever and mucositis in patients undergoing peripheral blood stem cell transplantation
  1. J Pardo Pastor,
  2. P March López,
  3. R Garriga,
  4. P Arcenillas Quevedo,
  5. S Redondo Capafons,
  6. E Clot Silla,
  7. M Longoni,
  8. M Trullàs,
  9. R Pla
  1. Hospital Universitari Mútua Terrassa, Pharmacy, Terrassa, Spain


Background Peripheral blood stem cell transplantation (PBSCT) has reduced morbidity and mortality and it is probably one of the most important of the autologous transplantations.

Purpose The objective is to describe the complications (neutropenic fever and mucositis) and progress observed in haematological patients undergoing a PBSCT.

Material and methods Observational, descriptive and retrospective study carried out during 2013 in a 500-bed university hospital. All patients undergoing a PBSCT were included in the study.

Two different groups were established, depending on the conditioning regime administered, depending on the usual clinical practice.

  • Group A: Patients treated with BCNU, etoposide and cytosine arabinoside and melphalan (BEAM)

  • Group B: Patients treated with melphalan

Data collected included: sex, age, types of conditioning regimen, NF and mucositis during the bone marrow aplasia phase, as well as the patients’ situation three months after the PBSCT.

Results During the bone marrow aplasia phase patients presented neutropenic fever and mucositis (Table 1).

Three months after the PBSCT, nine patients in group A presented a complete response, two patients partial response, and one patient success. In group B, ten patients presented complete response and one patient partial response.

Abstract CP-131 Table 1

Conclusion Most of the patients undergoing a PBSCT presented neutropenic fever and mucositis. Eight of them required an antimicrobial treatment of high complexity and 11 required parenteral nutritional support.

Three months after the PBSCT, the number of complete responses in group B was superior to those in group A.

References and/or Acknowledgements I wish to acknowledge the help provided by the pharmacy members.

No conflict of interest.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.